Decision to Cease Development of US Respiratory Product
Filed with ASX · · 2 pages · English
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings CallGenetic Signatures Ltd. on 6ix
Earlier from Genetic Signatures
- Leadership Transition at Genetic Signatures
- TGA authorises supply of updated Respiratory Detection Kit
- 1H 24 Market Update
- Genetic Signatures Rights Issue Offer Booklet
- Genetic Signatures Successfully Completes Placement
Later from Genetic Signatures
- Trading Halt
- FDA Clearance For Gastrointestinal Parasite Detection Kit
- Genetic Signatures Appoints Allison Rossiter As CEO
- Genetic Signatures Announces $30 Million Capital Raising
- FDA Clearance and Capital Raising Presentation
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures